|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.27/-0.19
|
Enterprise Value
3.01B
|
Balance Sheet |
Book Value Per Share
3.71
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
169.60M
|
Operating Revenue Per Share
1.18
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/06/03 01:40 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the United States which also generates key revenue, China, EMEA (Excluding Sweden) Japan, and other regions. |